Latest news
Loading news…
Avicenna Biosciences
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Durham, North Carolina, United States Founded 2020 11-50 employees For Profit
Avicenna Biosciences is a biotechnology company that redesigns and optimizes drug candidates.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Patents
9
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 9
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $229K
Company Info
- Founded
- 2020
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 23
- HQ
- Durham, North Carolina, United States
- Region
- Research Triangle, East Coast, Southern US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.1
- Trend (90d)
- -0.9
Key People at Avicenna Biosciences
Co-Founder & Board Member
Co-Founder & CSO
3
professional contacts at Avicenna Biosciences
Contact execs at Avicenna Biosciences →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Avicenna Biosciences
Loading news…
FAQs about Avicenna Biosciences
People who checked this page also checked these
Browse the full Acquirezy directory.